Cannabinoids and the expanded endocannabinoid system in neurological disorders

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607

Cannabinoids-Promising Antimicrobial Drugs or Intoxicants with Benefits?

Klahn, P. (2020) · Antibiotics · doi:10.3390/antibiotics9060297 · Cited by 43

Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies

Reddy, V. P., Grogan, D. P., Ahluwalia, M., Salles, É. L., Ahluwalia, P. K., Khodadadi, H., Alverson, K., Nguyen, A., Raju, S. P., Gaur, P., et al. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00203-4 · Cited by 45

Targeting the endocannabinoid system with microbial interventions to improve gut integrity

Jansma, J., Brinkman, F. N., van Hemert, S., & Aidy, S. E. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110169 · Cited by 45

Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome

Brierley, S. M., Meerveld, B. G., Sarnelli, G., Sharkey, K. A., Storr, M., & Tack, J. F. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00682-y · Cited by 41

A proposed modulatory role of the endocannabinoid system on adipose tissue metabolism and appetite in periparturient dairy cows

Myers, M. N., Zachut, M., Tam, J., & Contreras, G. A. (2021) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00549-3 · Cited by 43

The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders

Xin, Q., Xu, F., Taylor, D. H., Zhao, J., & Wu, J. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00530-2 · Cited by 41

Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review

Bryk, M., & Starowicz, K. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00270-y · Cited by 40

Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization

Grieco, M., Caris, M. G. D., Maggi, E., Armeli, F., Coccurello, R., Bisogno, T., D’Erme, M., Maccarrone, M., Mancini, P., & Businaro, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147711 · Cited by 39

Anti-Bacterial Effect of Cannabidiol against the Cariogenic Streptococcus mutans Bacterium: An In Vitro Study

Barak, T., Eden, S., Steinberg, D., Feldman, M., Sionov, R. V., & Shalish, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415878 · Cited by 39

Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells

Sarsembayeva, A., Kienzl, M., Gruden, E., Ristić, D., Maitz, K. S., Valadez-Cosmes, P., Santiso, A., Hasenoehrl, C., Brčić, L., Lindenmann, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997115 · Cited by 39

The endocannabinoid system – current implications for drug development

Fowler, C. J. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13229 · Cited by 38

Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions

Brown, J. D., Rivera, K. J. R., Hernandez, L. Y. C., Doenges, M. R., Auchey, I., Pham, T., & Goodin, A. J. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1871 · Cited by 43

Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD

Wang, S., Zhu, Q., Liang, G., Franks, T., Boucher, M., Bence, K. K., Lu, M., Castorena, C. M., Zhao, S., Elmquist, J. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152242 · Cited by 38

Metabolic Messengers: endocannabinoids

Busquets-García, A., Bolaños, J. P., & Marsicano, G. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00600-1 · Cited by 43

Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations

Aziz, A.-I., Nguyen, L. C., Oumeslakht, L., Bensussan, A., & Mkaddem, S. B. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0133 · Cited by 41

Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds

Lins, B. R., Anyaegbu, C. C., Hellewell, S. C., Papini, M. G., McGonigle, T. A., Prato, L. D., Shales, M., & Fitzgerald, M. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02734-9 · Cited by 40

Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches

Chen, H., Zeng, Y., Wang, D., Li, Y., Xing, J., Zeng, Y., Liu, Z., Zhou, X., & Fan, H. J. (2024) · Molecules · doi:10.3390/molecules29071478 · Cited by 41

Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice

Zhang, H., Shen, H., Gao, M., Ma, Z., Hempel, B. J., Bi, G., Gardner, E. L., Wu, J., & Xi, Z. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108538 · Cited by 38

Chronic Pain–Related Cognitive Deficits: Preclinical Insights into Molecular, Cellular, and Circuit Mechanisms

Han, S., Wang, J., Zhang, W., & Tian, X. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04073-z · Cited by 39

Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders

Fernández-Trapero, M., Pérez-Díaz, C., Espejo‐Porras, F., de Lago, E., & Fernández‐Ruíz, J. (2020) · Biomolecules · doi:10.3390/biom10020279 · Cited by 37

Add‐on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy

Kuchenbuch, M., D’Onofrio, G., Chémaly, N., Barcia, G., Teng, T., & Nabbout, R. (2020) · Epilepsia Open · doi:10.1002/epi4.12411 · Cited by 39

A biomolecule-free electrochemical sensing approach based on a novel electrode modification technique: Detection of ultra-low concentration of Δ⁹-tetrahydrocannabinol in saliva by turning a sample analyte into a sensor analyte

Ortega, G. A., Ahmed, S. R., Tuteja, S. K., Srinivasan, S., & Rajabzadeh, A. R. (2021) · Talanta · doi:10.1016/j.talanta.2021.122863 · Cited by 37

Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

Abd‐Nikfarjam, B., Dolati‐Somarin, A., Rahimi, V. B., & Askari, V. R. (2023) · BioFactors · doi:10.1002/biof.1936 · Cited by 37

Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1–Drp1 pathway

Yang, S., Hu, B., Wang, Z., Zhang, C., Jiao, H., Mao, Z.-G., Wei, L., Jia, J., & Zhao, J. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00338-3 · Cited by 36

Mediterranean Diet and Neurodegenerative Diseases: The Neglected Role of Nutrition in the Modulation of the Endocannabinoid System

Armeli, F., Bonucci, A., Maggi, E., Pinto, A., & Businaro, R. (2021) · Biomolecules · doi:10.3390/biom11060790 · Cited by 40

URB597 and Andrographolide Improve Brain Microvascular Endothelial Cell Permeability and Apoptosis by Reducing Oxidative Stress and Inflammation Associated with Activation of Nrf2 Signaling in Oxygen‐Glucose Deprivation

Wang, D., Kang, K., Sun, J., Lin, Q. D., Lv, Q., & Hai, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4139330 · Cited by 36

Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder

Zamberletti, E., Rubino, T., & Parolaro, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107878 · Cited by 36

Neuroprotective Effects of VEGF-A Nanofiber Membrane and FAAH Inhibitor URB597 Against Oxygen–Glucose Deprivation-Induced Ischemic Neuronal Injury

Wang, D., Jin, K.-Y., Zhao, P., Lin, Q. D., Kang, K., & Hai, J. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s307335 · Cited by 35

A Proteomic View of Cellular and Molecular Effects of Cannabis

Abyadeh, M., Gupta, V., Paulo, J. A., Gupta, V. B., Chitranshi, N., Godinez, A., Saks, D., Hasan, M. T., Amirkhani, A., McKay, M. J., et al. (2021) · Biomolecules · doi:10.3390/biom11101411 · Cited by 35

Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease

Wang, M., Liu, H., & Ma, Z. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.832854 · Cited by 36

Key Genes and Biochemical Networks in Various Brain Regions Affected in Alzheimer’s Disease

Abyadeh, M., Tofigh, N., Hosseinian, S., Hasan, M. T., Amirkhani, A., Fitzhenry, M. J., Gupta, V. B., Chitranshi, N., Salekdeh, G. H., Haynes, P. A., et al. (2022) · Cells · doi:10.3390/cells11060987 · Cited by 35

Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice

Paes-Colli, Y., Aguiar, A. F. L., Isaac, A. R., Ferreira, B. K., Campos, R. M. P., Trindade, P. M. P., Reis, R. A. D. M., & Sampaio, L. D. S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.917164 · Cited by 39

Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study

Bapir, L., Erridge, S., Nicholas, M., Pillai, M., Dalavaye, N., Holvey, C., Coomber, R., Hoare, J. M., Khan, S. A., Weatherall, M. W., et al. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2181696 · Cited by 59

Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases

Bukowska, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312738 · Cited by 42

Protective Effects of N-Oleoylglycine in a Mouse Model of Mild Traumatic Brain Injury

Piscitelli, F., Guida, F., Luongo, L., Iannotti, F. A., Boccella, S., Verde, R., Lauritano, A., Imperatore, R., Smoum, R., Cristino, L., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00633 · Cited by 34

Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis

Rodríguez‐Cueto, C., García‐Toscano, L., Santos‐García, I., Gómez‐Almería, M., Gonzalo‐Consuegra, C., Espejo‐Porras, F., Fernández‐Ruíz, J., & de Lago, E. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15386 · Cited by 34

Endocannabinoids Tune Intrinsic Excitability in O-LM Interneurons by Direct Modulation of Postsynaptic Kv7 Channels

Incontro, S., Sammari, M., Azzaz, F., Inglebert, Y., Ankri, N., Russier, M., Fantini, J., & Debanne, D. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1279-21.2021 · Cited by 32

Identification and validation of oxidative stress and immune-related hub genes in Alzheimer’s disease through bioinformatics analysis

Li, S., Xiao, J., Huang, C., & Sun, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-27977-7 · Cited by 35

Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets

Fellous, T. G., Maio, F. D., Kalkan, H., Carannante, B., Boccella, S., Petrosino, S., Maione, S., Marzo, V. D., & Iannotti, F. A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113859 · Cited by 37

The implications of late-life cannabis use on brain health: A mapping review and implications for future research

Weinstein, G., & Sznitman, S. R. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101041 · Cited by 33

Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?

Charytoniuk, T., Żywno, H., Konstantynowicz-Nowicka, K., Berk, K., Bzdęga, W., & Chabowski, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124221 · Cited by 33

Therapeutic potential of cannabinoids in combination cancer therapy

Malhotra, P., Casari, I., & Falasca, M. (2021) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100774 · Cited by 33

Cannabinoids: a class of unique natural products with unique pharmacology

Piscitelli, F., & Marzo, V. D. (2021) · RENDICONTI LINCEI · doi:10.1007/s12210-020-00966-y · Cited by 33

Antidepressant‐like effect of rosmarinic acid during LPS ‐induced neuroinflammatory model: The potential role of cannabinoid receptors/ PPAR ‐γ signaling pathway

Lataliza, A. A. B., de Assis, P. M., Laurindo, L. R., Gonçalves, E. C. D., Raposo, N. R. B., & Dutra, R. C. (2021) · Phytotherapy Research · doi:10.1002/ptr.7318 · Cited by 33

An update of nano-based drug delivery systems for cannabinoids: Biopharmaceutical aspects & therapeutic applications

Rebelatto, E. R. L., Rauber, G. S., & Caon, T. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122727 · Cited by 34

TNEA therapy promotes the autophagic degradation of NLRP3 inflammasome in a transgenic mouse model of Alzheimer’s disease via TFEB/TFE3 activation

Lin, W., Zhao, L., Liang, G., Zhou, R., Zheng, X., Tao, R., Huo, Q., Su, C.-F., Li, M., Xu, N., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02698-w · Cited by 32

The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD

Chu, F.-X., Wang, X., Li, B., Xu, L., & Di, B. (2024) · Inflammation Research · doi:10.1007/s00011-023-01831-y · Cited by 33

Sleep, Glial Function, and the Endocannabinoid System: Implications for Neuroinflammation and Sleep Disorders

Camberos-Barraza, J., Camacho-Zamora, A., Bátiz-Beltrán, J. C., Osuna‐Ramos, J. F., Rábago-Monzón, Á. R., Valdez-Flores, M. A., Angulo‐Rojo, C., Guadrón‐Llanos, A. M., Picos-Cárdenas, V. J., Calderón-Zamora, L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063160 · Cited by 36

Role of cannabinoids in alcohol-induced neuroinflammation

García-Baos, A., Alegre-Zurano, L., Cantacorps, L., Martín‐Sánchez, A., & Valverde, O. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110054 · Cited by 34

Ligands for oral delivery of peptides across the blood-brain-barrier

Gailani, M. A., Liu, M., & Wen, J. (2022) · Acta Materia Medica · doi:10.15212/amm-2021-0007 · Cited by 31

Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review

Rodrigues, L. A., Caroba, M. E. S., Taba, F. K., Filev, R., & Gallassi, A. D. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172982 · Cited by 31

CB2 receptor‐selective agonists as candidates for targeting infection, inflammation, and immunity in SARS‐CoV ‐2 infections

Meeran, M. F. N., Sharma, C., Goyal, S. N., Kumar, S., & Ojha, S. K. (2020) · Drug Development Research · doi:10.1002/ddr.21752 · Cited by 32

Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression

Silveira, K. M., Wegener, G., & Joca, S. R. L. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13595 · Cited by 30

Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation

Kibret, B. G., Canseco-Alba, A., Onaivi, E. S., & Engidawork, E. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1137957 · Cited by 30

Challenges of Cannabinoid Delivery: How Can Nanomedicine Help?

Onaivi, E. S., Chauhan, B. P. S., & Sharma, V. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0221 · Cited by 30

Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease

Rapaka, D., Bitra, V. R., Challa, S. R., & Adiukwu, P. C. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102196 · Cited by 29

The endocannabinoid system and related lipids as potential targets for the treatment of migraine‐related pain

Greco, R., Demartini, C., Zanaboni, A. M., Francavilla, M., Icco, R. D., Ahmad, L., & Tassorelli, C. (2022) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14267 · Cited by 45

The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption

Ding, W., Yang, L., Shi, E., Kim, B., Low, S. A., Hu, K., Gao, L., Chen, P., Ding, W. Y., Borsook, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42283-6 · Cited by 29

Chemical Probes to Control and Visualize Lipid Metabolism in the Brain

Punt, J. M., van der Vliet, D., & van der Stelt, M. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.2c00521 · Cited by 29

Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments

Satta, V., Alonso, C., Díez, P., Martín‐Suárez, S., Rubio, M., Encinas, J. M., Fernández‐Ruíz, J., & Sagredo, O. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.602801 · Cited by 28

Selective Endocannabinoid Reuptake Inhibitor WOBE437 Reduces Disease Progression in a Mouse Model of Multiple Sclerosis

Reynoso-Moreno, I., Tietz, S., Vallini, E., Engelhardt, B., Gertsch, J., & Chicca, A. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00214 · Cited by 28

The CB2 cannabinoid receptor as a therapeutic target in the central nervous system

Cabañero, D., Martín‐García, E., & Maldonado, R. J. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1971196 · Cited by 30

Sphingolipid and Endocannabinoid Profiles in Adult Attention Deficit Hyperactivity Disorder

Brunkhorst-Kanaan, N., Trautmann, S., Schreiber, Y., Thomas, D., Kittel‐Schneider, S., Gurke, R., Geißlinger, G., Reif, A., & Tegeder, I. (2021) · Biomedicines · doi:10.3390/biomedicines9091173 · Cited by 28

Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota

Suriano, F., Manca, C., Flamand, N., Depommier, C., Hul, M. V., Delzenne, N. M., Silvestri, C., Cani, P. D., & Marzo, V. D. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159056 · Cited by 28

Gut Microbiome and Plasma Metabolome Signatures in Middle-Aged Mice With Cognitive Dysfunction Induced by Chronic Neuropathic Pain

Hua, D., Li, S., Li, S., Wang, X., Wang, Y., Xie, Z., Zhao, Y., Zhang, J., & Luo, A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.806700 · Cited by 29

Cannabidiol and epilepsy in Brazil: a current review

Oshiro, C. A., & Castro, L. H. M. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2022-s137 · Cited by 37

Peripheral changes of endocannabinoid system components in episodic and chronic migraine patients: A pilot study

Greco, R., Demartini, C., Zanaboni, A. M., Tumelero, E., Icco, R. D., Sances, G., Allena, M., & Tassorelli, C. (2020) · Cephalalgia · doi:10.1177/0333102420949201 · Cited by 27

Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention

Oleson, E. B., Hamilton, L. R., & Gomez, D. M. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.660218 · Cited by 28

Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects

Ward, S. J., Lichtman, A. H., Piomelli, D., & Parker, L. A. (2021) · JNCI Monographs · doi:10.1093/jncimonographs/lgab007 · Cited by 29

Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine

Challal, S., Skiba, A., Langlois, M., Esguerra, C. V., Wolfender, J., Crawford, A. D., & Skalicka‐Woźniak, K. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116740 · Cited by 29

Extracellular vesicles released by microglia and macrophages carry endocannabinoids which foster oligodendrocyte differentiation

Lombardi, M., Scaroni, F., Gabrielli, M., Raffaele, S., Bonfanti, E., Filipello, F., Giussani, P., Picciolini, S., de Rosbo, N. K., Uccelli, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1331210 · Cited by 29

Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease

Kanwal, H., Sangineto, M., Ciarnelli, M., Castaldo, P., Villani, R., Romano, A. D., Serviddio, G., & Cassano, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074050 · Cited by 28

Lysophosphatidylserine: A Signaling Lipid with Implications in Human Diseases

Chakraborty, A., & Kamat, S. S. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00701 · Cited by 24

Cannabinoid Receptor Type 2 Ligands: An Analysis of Granted Patents Since 2010

Brennecke, B., Gazzi, T., Atz, K., Fingerle, J., Kuner, P., Schindler, T., WECK, G. D., Nazaré, M., & Grether, U. (2021) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2021-0002 · Cited by 25

Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson’s Disease

Gu, C., Chen, Y., Chen, Y., Liu, C., Zhu, Z., & Wang, M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.768156 · Cited by 26

Lipid endocannabinoids in energy metabolism, stress and developmental programming

de Almeida, M. M., Dias-Rocha, C. P., Calviño, C., & Trevenzoli, I. H. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111522 · Cited by 27

Impact of the Cannabinoid System in Alzheimer's Disease

Li, S., Huang, Y., Yu, L., Ji, X., & Wu, J. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220201091006 · Cited by 28

Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats

Schiavi, S., Manduca, A., Carbone, E., Buzzelli, V., Rava, A., Feo, A., Ascone, F., Morena, M., Campolongo, P., Hill, M. N., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01454-7 · Cited by 26

Manipulation of the diet–microbiota–brain axis in Alzheimer’s disease

Lee, D. D., Lee, V. M. ‐., & Hur, S. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1042865 · Cited by 27

Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment

Berk, K., Bzdęga, W., Konstantynowicz-Nowicka, K., Charytoniuk, T., Żywno, H., & Chabowski, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030393 · Cited by 25

Endocannabinoids in Bladder Sensory Mechanisms in Health and Diseases

Christie, S., Brookes, S. J., & Zagorodnyuk, V. P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.708989 · Cited by 25

Microglial Endocannabinoid Signalling in AD

Scipioni, L., Ciaramellano, F., Carnicelli, V., Leuti, A., Lizzi, A. R., Dominicis, N. D., Oddi, S., & Maccarrone, M. (2022) · Cells · doi:10.3390/cells11071237 · Cited by 26

Protective Effects of Cannabinoid Type 2 Receptor Activation Against Microglia Overactivation and Neuronal Pyroptosis in Sepsis-Associated Encephalopathy

Liu, Y., Li, Z., Xu, Z., Zhang, B., Liu, A., He, Q., Zheng, F., & Zhan, J. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.04.011 · Cited by 28

Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes

Meo, C. D., Tortolani, D., Standoli, S., Angelucci, C. B., Fanti, F., Leuti, A., Sergi, M., Kadhim, S., Hsu, E., Rapino, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105430 · Cited by 24

CBGA ameliorates inflammation and fibrosis in nephropathy

Suzuki, S., Fleig, A., & Penner, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-33507-2 · Cited by 25

Spinal cannabinoid receptor 2 activation alleviates neuropathic pain by regulating microglia and suppressing P2X7 receptor

Zhou, Y., Xu, Y., Yang, J., Yu, Z., Wang, W., Yuan, M., Wang, Y., Bai, Q., & Li, Z. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1061220 · Cited by 24

Structural basis of THC analog activity at the Cannabinoid 1 receptor

Thorsen, T. S., Kulkarni, Y., Sykes, D. A., Bøggild, A., Drace, T., Hompluem, P., Iliopoulos‐Tsoutsouvas, C., Nikas, S. P., Daver, H., Makriyannis, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55808-4 · Cited by 28

Role of 2-Arachidonoyl-Glycerol and CB1 Receptors in Orexin-A-Mediated Prevention of Oxygen–Glucose Deprivation-Induced Neuronal Injury

Palomba, L., Motta, A., Imperatore, R., Piscitelli, F., Capasso, R., Mastroiacovo, F., Battaglia, G., Bruno, V., Cristino, L., & Marzo, V. D. (2020) · Cells · doi:10.3390/cells9061507 · Cited by 24

Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy

Zaiachuk, M., Pryimak, N., Kovalchuk, O., & Kovalchuk, I. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.713153 · Cited by 24

The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models

Pietropaolo, S., & Marsicano, G. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.031 · Cited by 23

Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis

Khan, H., Ghori, F. K., Ghani, U., Javed, A., & Zahid, S. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07223-5 · Cited by 24

Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy

Nielsen, S. W., Hasselsteen, S. D., Dominiak, H. S. H., Labudovic, D., Reiter, L., Dalton, S. O., & Herrstedt, J. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07312-y · Cited by 24

Update on the controversial identity of cells expressing cnr2 gene in the nervous system

Grabon, W., Bodennec, J., Rheims, S., Belmeguenaï, A., & Bezin, L. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13977 · Cited by 24

Development of cannabidiol derivatives as potent broad-spectrum antibacterial agents with membrane-disruptive mechanism

Fang, S., Kang, W.-T., Li, H., Cai, Q., Liang, W., Zeng, M., Yu, Q., Zhong, R., Tao, Y., Liu, S., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116149 · Cited by 24

The role of the endocannabinoid system in autism spectrum disorders: Evidence from mouse studies

Pietropaolo, S., Bellocchio, L., Bouzón‐Arnáiz, I., & Yee, B. K. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.016 · Cited by 24

The Synthetic Cannabinoids THJ-2201 and 5F-PB22 Enhance In Vitro CB1 Receptor-Mediated Neuronal Differentiation at Biologically Relevant Concentrations

Alexandre, J., Malheiro, R. F., da Silva, D. D., Carmo, H., Carvalho, F. D., & Silva, J. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176277 · Cited by 24

Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells

Jing, H., Reed, A., Ulanovskaya, O. A., Grigoleit, J.-S., Herbst, D. M., Henry, C. L., Li, H., Barbas, S., Germain, J., Masuda, K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112971118 · Cited by 24

Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery

Shen, S., Wu, C., Yang, Z., Wang, K., Shao, Z., & Yan, W. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01472-9 · Cited by 23

Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study

Chester, L. A., Englund, A., Chesney, E., Oliver, D., Wilson, J., Sovi, S., Dickens, A. M., Orešič, M., Linderman, T., Hodsoll, J. P., et al. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0174 · Cited by 24

Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer’s disease: A systematic review and meta-analysis of animal studies

Kamaruzzaman, M. A., Romli, M. H., Abas, R., Vidyadaran, S., Baharuldin, M. T. H., Nasaruddin, M. L., Vishnumukkala, T., Sura, S., Warsito, K., Nor, N. H. M., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1053680 · Cited by 25

Endocannabinoidome and its role in neurological disorders-A comprehensive update of existing literature

Dutta, R. (2021) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001049 · Cited by 1

Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders

Estrada, J. A., & Contreras, I. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200217140255 · Cited by 33

Discovery of the Endocannabinoid System: A Breakthrough in Neuroscience

Hassanzadeh, P. (2014) · Archives of Neuroscience · doi:10.5812/archneurosci.15030 · Cited by 3

Endocannabinoids Part II: pathological CNS conditions involving the endocannabinoid system and their possible treatment with endocannabinoid-based drugs

Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2001) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.5.3.349 · Cited by 4

Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies

Duncan, R. S., Riordan, S. M., Gernon, M. C., & Koulen, P. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382220 · Cited by 30